Oral Chemotherapy for Cancer of the Colon after Surgery, Metastatic Breast and Colorectal Cancer
XELODA is the first FDA-approved oral chemotherapy for the treatment of both
metastatic breast and colorectal cancers. That means it can be taken by mouth.
XELODA has been proven to be effective at treating metastatic breast cancer and
colorectal cancer in several clinical studies. It has also been shown to be
generally tolerated well by patients.
The Benefits of an Oral Chemotherapy
Because XELODA can be taken by mouth, it can be more convenient than intravenous (IV)
chemotherapy. IV therapy typically means a visit to your doctor's office, a clinic, or a hospital.
With XELODA, you may be able to have fewer visits, or at least have each one take less time. Plus,
you can take XELODA when you're at home, at work, or even while traveling. This can be more
difficult with an IV chemotherapy.
For example, the Mayo Clinic's recommended schedule for treating colon cancer
require up to 30 clinic visits over a 24-week treatment course. Patients taking
XELODA (capecitabine) for colon cancer generally requires fewer clinic visits.
Learn More About XELODA
This section of XELODA.com has information to help patients and their caregivers learn more
About XELODA,
how it works,
and
possible side effects.
This information does not take the place of talking to your healthcare professional about your medical
condition or your
metastatic breast cancer and
colorectal cancer treatment options. Use the information you find here to help plan your discussion about XELODA
with your doctor.